Vipergen R & D IV K/S — Credit Rating and Financial Key Figures
CVR number: 41868104
Gammel Kongevej 23 A, 1610 København V
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| External services | -8 396.57 | -33.18 | -8.00 | -4 008.03 |
| Gross profit | -8 396.57 | -33.18 | -8.00 | -4 008.03 |
| EBIT | -8 396.57 | -33.18 | -8.00 | -4 008.03 |
| Other financial income | 82.92 | 110.89 | 104.69 | |
| Other financial expenses | -0.25 | -0.07 | ||
| Pre-tax profit | -8 396.57 | 49.49 | 102.81 | -3 903.34 |
| Net earnings | -8 396.57 | 49.49 | 102.81 | -3 903.34 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Tangible assets total | ||||
| Investments total | ||||
| Long term receivables total | ||||
| Inventories total | ||||
| Current other receivables | 1 250.00 | 4 450.49 | 4 530.89 | 627.55 |
| Short term receivables total | 1 250.00 | 4 450.49 | 4 530.89 | 627.55 |
| Cash and bank deposits | 7.00 | 21.41 | 21.41 | |
| Cash and cash equivalents | 7.00 | 21.41 | 21.41 | |
| Balance sheet total (assets) | 1 250.00 | 4 457.49 | 4 552.30 | 648.96 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Share capital | 15 000.00 | 15 000.00 | 15 000.00 | 15 000.00 |
| Other restricted equity | -5 361.43 | -2 211.43 | -2 211.43 | -2 211.43 |
| Retained earnings | -8 396.57 | -8 347.08 | -8 244.27 | |
| Profit of the financial year | -8 396.57 | 49.49 | 102.81 | -3 903.34 |
| Shareholders equity total | 1 242.00 | 4 441.49 | 4 544.30 | 640.96 |
| Non-current liabilities total | ||||
| Current trade creditors | 8.00 | 16.00 | 8.00 | 8.00 |
| Current liabilities total | 8.00 | 16.00 | 8.00 | 8.00 |
| Balance sheet total (liabilities) | 1 250.00 | 4 457.49 | 4 552.30 | 648.96 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.